INS and Alzheimer disease: Remarkably, Paladugu et al. found that liraglutide treatment proved more effective in reducing neuroinflammation and restoring disrupted insulin signaling in prodromal streptozotocin (STZ)/sporadic AD mice compared to prodromal 5×FAD (five AD-linked mutations) mice.